Proteomics and immunohistochemistry identify loss of nucleophosmin (B23) expression in bladder transitional cell carcinomas

Proteomics and immunohistochemistry identify loss of nucleophosmin (B23) expression in bladder transitional cell carcinomas

書誌詳細
主要な著者:	Ahmad, M, Catto, J, Azzouzi, A, Cross, S, Feeley, K, Eaton, C, Meuth, M, Hamdy, F, Rehman, I
フォーマット:	Journal article
言語:	English
出版事項:	2003

類似資料

Proteomic analysis of voided urine following prostatic massage reveals tumour specific alterations
著者:: Rehman, I, 等
出版事項: (2004)

Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
著者:: Rehman, I, 等
出版事項: (2004)

Tissue microarray immunohistochemistry and cluster analysis confirms the validity of candidate proteins in prostate cancer identified by proteomic analysis of urine
著者:: Rehman, I, 等
出版事項: (2005)

A gene promoter hypermethylation panel to detect transitional cell carcinoma of the bladder
著者:: Yates, DR, 等
出版事項: (2006)

Genetic instability and transitional cell carcinoma of the bladder.
著者:: Catto, J, 等
出版事項: (2004)

Calgizzarin (S100A11) immunostaining pattern is altered in prostate cancer suggesting a role in tumourigenesis
著者:: Rehman, I, 等
出版事項: (2003)

Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma.
著者:: Catto, J, 等
出版事項: (2005)

Promoter hypermethylation identifies progression risk in bladder cancer.
著者:: Yates, DR, 等
出版事項: (2007)

The use of proteomics in urological research
著者:: Rehman, I, 等
出版事項: (2005)

Methylational urinalysis: a prospective study of bladder cancer patients and age stratified benign controls.
著者:: Yates, DR, 等
出版事項: (2006)

Comparing gene promoter methylation frequencies in urine from patients with bladder cancer with urine from non-cancerous young and elderly control patients
著者:: Yates, DR, 等
出版事項: (2005)

FGFR3 mutations indicate better survival in invasive upper urinary tract and bladder tumours.
著者:: van Oers, J, 等
出版事項: (2009)

Clinically localised prostate cancer is microsatellite stable.
著者:: Azzouzi, A, 等
出版事項: (2007)

Distinct patterns of microsatellite instability are seen in tumours of the urinary tract.
著者:: Catto, J, 等
出版事項: (2003)

Loss of intercellular expression of beta-dystroglycan is a common event in prostate cancer and is significantly associated with loss of differentiation
著者:: Cross, S, 等
出版事項: (2005)

A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis
著者:: Carolien M. Woolthuis, 等
出版事項: (2013-10-01)

Itraq-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression
著者:: Rehman, I, 等
出版事項: (2008)

iTRAQ-facilitated proteomic analysis of human prostate cancer cells identifies proteins associated with progression.
著者:: Glen, A, 等
出版事項: (2008)

Phosphorylation-dependent migration of retinoblastoma protein into the nucleolus triggered by binding to nucleophosmin/B23.
著者:: Takemura, M, 等
出版事項: (2002)

Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma.
著者:: Dhawan, D, 等
出版事項: (2006)

Involvement of nucleophosmin (NPM1/B23) in assembly of infectious HPV16 capsids
著者:: Patricia M. Day, 等
出版事項: (2015-12-01)

Development of a prognostic marker panel in bladder cancer using aberrant promoter methylation
著者:: Catto, J, 等
出版事項: (2007)

Aberrant promoter methylation in pre-malignant and invasive tumours of the urinary bladder
著者:: Yates, D, 等
出版事項: (2005)

Urinary Bladder Xanthoma – Is Immunohistochemistry Necessary?
著者:: M. Raghavendran, 等
出版事項: (2016-09-01)

DNA promoter methylation in urothelial cancer: a feature of the invasive phenotype and a novel therapeutic target
著者:: Catto, J, 等
出版事項: (2006)

Differential expression of hMLH1 and hMSH2 is related to bladder cancer grade, stage and prognosis but not microsatellite instability.
著者:: Catto, J, 等
出版事項: (2003)

Prostate cancer proteomics: The urgent need for clinically validated biomarkers
著者:: Evans, C, 等
出版事項: (2009)

Gli1 appears to be constitutively expressed in the lumenal epithelial cells of the prostate but not in the basal cell layer or the mesenchyme
著者:: Spencer, A, 等
出版事項: (2004)

Artificial intelligence in predicting bladder cancer outcome: a comparison of neuro-fuzzy modeling and artificial neural networks.
著者:: Catto, J, 等
出版事項: (2003)

Nucleophosmin 1 expression in acute myeloid leukemia
著者:: Mohammad Davoudi, 等
出版事項: (2015-10-01)

Nucleophosmin 1 expression in acute myeloid leukemia
著者:: Mohammad Davoudi, 等
出版事項: (2015-09-01)

Promoter hyper-methylation of calcium binding proteins S100A6 and S100A2 in human prostate cancer.
著者:: Rehman, I, 等
出版事項: (2005)

Epigenetic changes in urothelial cancer: A feature of the invasive phenotype and a novel therapeutic target
著者:: Catto, J, 等
出版事項: (2006)

NSC348884 cytotoxicity is not mediated by inhibition of nucleophosmin oligomerization
著者:: Markéta Šašinková, 等
出版事項: (2021-01-01)

Microsatellite instability as indicator of MSH2 gene mutation in patients with upper urinary tract transitional cell carcinoma.
著者:: Roupret, M, 等
出版事項: (2004)

Cucurbitacin B inhibits human breast cancer cell proliferation through disruption of microtubule polymerization and nucleophosmin/B23 translocation
著者:: Duangmano Suwit, 等
出版事項: (2012-10-01)

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.
著者:: Rouprêt, M, 等
出版事項: (2005)

Dysregulated expression of S100A11 (calgizzarin) in prostate cancer and precursor lesions.
著者:: Rehman, I, 等
出版事項: (2004)

Targeting chemotherapy to advanced bladder cancer patients most likely to benefit.
著者:: Catto, J, 等
出版事項: (2010)

Nucleophosmin phosphorylation by v-cyclin-CDK6 controls KSHV latency.
著者:: Grzegorz Sarek, 等
出版事項: (2010-03-01)